gtoffoli@cro.it

Share Your Research and Join the Pharma Hub

InnovationFlow is a Project by

Home
About The Project
Company Registration
Researcher Registration
Login

About gtoffoli@cro.it

Posts by gtoffoli@cro.it:

Sorry, nothing found.

Latest Project Added

CIC-39: A Novel Promising Small Molecule For The Treatment Of Tubular Aggregate Myopathies and Duchenne Muscular Dystrophy

December 12, 2022 6:42 pm
Predictive kit to identify patients not responding to platinum therapy

December 12, 2022 6:41 pm
Therapeutic agent delivery system based on Adipose Stromal/Stem Cells

October 5, 2022 4:38 pm
Drug-like inhibitors of endoplasmic oxido-reductin 1 (ERO1) and Unfolded protein response to fight cancer

May 2, 2022 4:38 pm
METHOD FOR CARRYING OUT IN VITRO MOLECULAR DIAGNOSIS OF OVARIAN TUMOR AND KIT

May 2, 2022 4:37 pm

Projects TAG Cloud

acetyl-L-carnitine Alzheimer's Disease; tau protein; immunotherapy; monoclonal antibody antimicrobials Astragalus membranaceus Centella asiatica CRM197 Diphtheria Toxin drug delivery dysbiosis Immunological Mechanism immunotherapy long lasting peptides medical device new therapy oncology ovarian cancer patch-clamp personalized medicine plants safety pharmacology selective inhibitors stenosis reduction tendinopathy tenocytes Visceral pain

Recent Posts

In this situation, we have across-referenced data which have Indeed
They tend are to 10-15%, however, they generally go of up to 50% within better VIP accounts
You will not get earnings directly from your own Zula Gambling enterprise extra
Parece handelt zigeunern infolgedessen erwartet damit Betrage bei nine � weiters 40 �
Unter zuhilfenahme von dennoch four Eur booten und trotzdem die gesamtheit kosten?

Recent Comments

MOriggi on NEK6 kinase inhibitors useful for the treatment of solid tumors

Archives

Categories

Uncategorized

Meta

Register
Log in
Entries feed
Comments feed
WordPress.org

© InnovationFlow 2026 - Privacy - Contact InnovationFlow

Powered by Artemida.it